GELMEDIX
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reduce the usage of drops which cause inconvenience to patients.
GELMEDIX
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.gelmedix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google Google Cloud Sectigo SSL Sectigo Domain SSL
Current Employees Featured
Founder
Investors List
Safar Partners
Safar Partners investment in Seed Round - Gelmedix
HTL Innovations
HTL Innovations investment in Seed Round - Gelmedix
EQx Fund
EQx Fund investment in Convertible Note - Gelmedix
Safar Partners
Safar Partners investment in Convertible Note - Gelmedix
Official Site Inspections
http://www.gelmedix.com Semrush global rank: 5.99 M Semrush visits lastest month: 1.37 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Gelmedix"
Home | GelMEDIX, Inc.
GelMEDIX was founded after multiple years of fruitful academic collaboration between our co-founders Reza Dana (Mass. Eye And Ear, Harvard Med. School) and Nasim Annabi (UCLA). …See details»
Gelmedix - Crunchbase Company Profile & Funding
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non …See details»
GelMedix - VentureRadar
GelMEDIX can replace today’s drug regimens that require application of eye drops 4-12x per day over several weeks with a single, non-invasive gel patch. GelMEDIX’s gel could also be used …See details»
GelMEDIX Company Profile 2025: Valuation, Funding
GelMEDIX General Information Description. Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative …See details»
GelMEDIX, Inc. Company Profile | Newton, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GelMEDIX, Inc. of Newton, MA. Get the latest business insights from Dun & Bradstreet.See details»
Gelmedix - Funding, Financials, Valuation & Investors - Crunchbase
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
Team | GelMEDIX, Inc.
Max works at the intersection of science and business operations for GelMEDIX, and has been with the team since company founding. Prior to GelMEDIX, he completed his PhD in …See details»
GelMEDIX - Products, Competitors, Financials, Employees, …
GelMEDIX operates an early-stage biotechnology company focused on developing ocular cell therapies and regenerative treatments to restore vision. Its offerings include engineering …See details»
GelMEDIX - Company Profile - Tracxn
Jan 18, 2025 Corporates and Startups. Corp Dev and M&A Teams Corporate Innovation Startup Founders Sales Team. EcosystemSee details»
GelMEDIX - LinkedIn
GelMEDIX | 621 followers on LinkedIn. Technology to revolutionize ocular cell therapies | GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to …See details»
GelMEDIX, Inc. - BIO International Convention 2025
GelMEDIX's proprietary, in situ forming hydrogel technology provides an injectable scaffold that protects cells and provides a framework for tissue regeneration. GelMEDIX has demonstrated …See details»
HTL announces its incubator's equity investment in GelMEDIX, an …
Mar 1, 2022 About GelMEDIX GelMEDIX Inc. is an early-stage biotechnology company committed to innovating the next generation of ocular and regenerative therapies through its …See details»
Our Technology - GelMEDIX, Inc.
GelMEDIX's proprietary injectable, in situ forming hydrogel technology overcomes the fundamental challenges of cell replacement therapies and has been shown in vivo to improve …See details»
GelMEDIX investment - HTL Biotechnology
Mar 10, 2022 GelMEDIX HTL announces its incubator’s equity investment in GelMEDIX, an early-stage biotech aiming at revolutionizing ocular and regenerative therapies. This …See details»
GelMEDIX Latest SEC Filings | CapEdge
GelMEDIX Filings. Company Profile < Back. Search within these filings. View filings. Categorized; Chronological; Export filings list. Export a CSV file of filings or unique filing companies (up to …See details»
Full List of Medical Device Companies in Massachusetts (2024)
Sep 24, 2024 There are over 500 manufacturing medical device companies in Massachusetts. The Boston area is a leading medical device cluster, but other areas like Cambridge, …See details»
News - GelMEDIX, Inc.
Mar 10, 2022 GelMEDIX is excited to present never-before-seen data on novel approaches to RPE regeneration at the upcoming ARVO and OIS Retina conferences in Seattle. We'll share …See details»
OIS XII Presenting Companies | Ophthalmology Innovation Source
GelMEDIX is conducting in-vivo proof-of-concept studies to support early 2023 Series A fundraising with a goal to achieve an IND submission and prepare for clinical study. GelMEDIX …See details»
PARTICIPATING COMPANIES
Biotech Showcase attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize …See details»
GelMedix selects Sapio Informatics Platform for LIMS system and ...
Sapio Platform – Configurable Lab Informatics Unify your lab. The industry’s first Science-aware™ lab informatics platform. Sapio LIMS® – Laboratory Information Management System A no …See details»